Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhaopei Liu
Observed names:
Liu, Zhaopei,
ZhaoPei Liu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Tiangong University,
Fudan University,
Third Hospital of Hebei Medical University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0002-5288-5037
Observed ORCID:
0000-0002-5288-5037
OpenAlex ID:
A5032831981
Intratumoral CXCL13 + CD8 + T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
2021
·
Siyuan Dai
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
260
PDF
Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
2020
·
Zhaopei Liu
, Quan Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
146
PDF
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
2022
·
Yijia Xu
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
108
PDF
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
2020
·
Ying Xiong
, Zewei Wang
, et al.
·
Journal for ImmunoTherapy of Cancer
·
63
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer
2020
·
Tao Wang
, Quan Zhou
, et al.
·
Cancer Immunology Immunotherapy
·
59
Tumor-infiltrating TNFRSF9 + CD8 + T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
2020
·
Yaohui Li
, Zewei Wang
, et al.
·
OncoImmunology
·
59
Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
2020
·
Han Zeng
, Quan Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
55
PDF
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer
2021
·
Mengmeng Sun
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
52
CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer
2022
·
Kaifeng Jin
, Yanze Yu
, et al.
·
British Journal of Cancer
·
44
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
2020
·
Quan Zhou
, Yangyang Qi
, et al.
·
Journal for ImmunoTherapy of Cancer
·
44
PDF
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer
2022
·
Zhaopei Liu
, Kaifeng Jin
, et al.
·
European Journal of Cancer
·
21
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin + cell abundance
2020
·
Quan Zhou
, Zewei Wang
, et al.
·
OncoImmunology
·
20
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Zhaopei Liu
, Han Zeng
, et al.
·
British Journal of Cancer
·
19
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Sen Yan
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1 / PD‐L1 blockade response in urothelial carcinoma
2024
·
Kaifeng Jin
, Jingtong Xu
, et al.
·
The Journal of Pathology
·
16
Poor clinical outcomes and immunoevasive contexture in interleukin‐9 abundant muscle‐invasive bladder cancer
2020
·
Quan Zhou
, Hongyu Zhang
, et al.
·
International Journal of Cancer
·
15
PDF
Tumor-infiltrating IL-17A + cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
2020
·
Zewei Wang
, Quan Zhou
, et al.
·
OncoImmunology
·
14
PDF
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer
2024
·
Bingyu Li
, Kaifeng Jin
, et al.
·
Cancer Immunology Immunotherapy
·
12
PDF
Intratumoral CCR5 + neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
2020
·
Zhuoyi Xiang
, Quan Zhou
, et al.
·
OncoImmunology
·
12
PDF
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5 + CD8 + T cell abundance
2020
·
Qiuren Huang
, Quan Zhou
, et al.
·
OncoImmunology
·
12
Exploring Chinese Dietary Habits Using Recipes Extracted From Websites
2019
·
Chuitian Rong
, Zhaopei Liu
, et al.
·
IEEE Access
·
12
PDF
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
2024
·
Ge Liu
, Kaifeng Jin
, et al.
·
Cancer Medicine
·
9
PDF
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
2024
·
Xiaohe Su
, Kaifeng Jin
, et al.
·
British Journal of Cancer
·
9
PDF
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
2023
·
Wandi Li
, Zhaopei Liu
, et al.
·
BMC Cancer
·
9
PDF
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
2022
·
Yanze Yu
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
9
Show more works
View as search
Works count:
62
Citation count:
1,160
H-index:
15
I10-index:
21
Year
Topic
Type